Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

April 20, 2020Open Access

Ver artículo completo

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

FSFábio Pittella SilvaUniversidade de Brasília YCYoon Ming ChinJapanese Foundation For Cancer Research TCTing ChanThe University of Melbourne

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The use of serum in retrospective studies should consider the limitations for detecting low AF mutations. Plasma is clearly preferable for prospective clinical applications of liquid biopsy.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Silva et al. (Mon,) studied this question.

synapsesocial.com/papers/69dc0d57a1150c2c259c7c71 https://doi.org/https://doi.org/10.1093/clinchem/hvaa103

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy? | Synapse